Studies examine cost-effectiveness of maternal RSV vaccination and nirsevimab in infants
Seasonal maternal respiratory syncytial virus (RSV) vaccination and nirsevimab for infants demonstrate cost-effectiveness, according to two studies published online Nov. 25 in Pediatrics.
News Medical on MSN5d
Scientists analyze virus protein structure to advance RSV vaccines
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) ...
Medscape1mon
Respiratory Syncytial Virus Protein Structure, Function and Implications for Subunit Vaccine Development
Future Virology. 2014;9(8):753-767. CHF: Congestive heart failure; CLD: Chronic lung disease; F: Fusion; G: Glyco; GLA-SE: Glucopyranosyl lipid A-stable emulsion; GMT ...
technologynetworks1mon
RSV pre-F Protein: Innovative Tool for Structure-Based Vaccine Evaluation
The trimeric pre-fusion glycoprotein F is essential for accurately assessing the immunogenicity of RSV vaccines. We strictly adhere to regulations to provide high-quality, consistent, native ...